Biomedical In Vivo Studies with ORMOSIL Nanoparticles Containing Active Agents.
Sign Up to like & getrecommendations! Published in 2020 at "Methods in molecular biology"
DOI: 10.1007/978-1-0716-0319-2_9
Abstract: Organically modified silica (ORMOSIL) nanoparticles have found many biomedical applications and emerged as biocompatible and efficient carriers of diagnostic and therapeutic agents, such as fluorophores, drugs, and DNA. Herein, we describe two major in vivo… read more here.
Keywords: ormosil nanoparticles; active agents; biomedical vivo; vivo studies ... See more keywords